With the advancement in the field of technology, women-centric startups are on the rise. While there are many health-centric ones, a majority of them exist in the fertility sector. The reason is that there are reports that one in six couples find difficulty in conceiving and opt for treatments to get pregnant.
As the global fertility market is worth several billions, startups in this space are securing investments like never before. As entrepreneurs want to catch in on this growing market, there are many such innovative fertility startups that help couples give birth to babies of the future. Today, we have curated a list of innovative fertility startups in Europe as sourced from Dealroom.
Apricity (France)
Founders: Caroline Noublanche
Total Funding: €6 million
Valuation: €24 million to €36 million
Founded Year: 2019
Why its hot: Femtech startup Apricity combines human care with the latest technologies such as Artificial Intelligence to improve chances of conception. With this service, prospective parents can stay connected with the best healthcare professionals and reduce the psychological pressure caused by fertility treatments.
Ava (Switzerland)
Founders: Lea von Bidder, Pascal Koenig, Peter Stein, Philipp Tholen
Total Funding: €41.2 million
Valuation: $120 million to $180 million
Founded Year: 2014
Why its hot: Zurich-based Ava won the Swiss Startups Awards in 2017 and Best of Baby Tech CES 2017 award as well. The medtech startup has developed a fertility tracking sensor bracelet, which is aimed to help women find out their fertile days with 90% accuracy. This bracelet can track nine physiological parameters including pulse rate, heat loss temperature and more to provide precise data.
Clue App (Germany)
Founders: Hans Raffauf, Ida Tin, Moritz von Buttlar
Total Funding: €73 million to €109 million
Valuation: €27.4 million
Founded Year: 2013
Why its hot: Clue is a menstrual tracking app, a resource for your health and a resource for your health. By creating a Clue account, you will get personal insights about the cycle. It lets you share your menstrual cycle with a partner or friend and the cycle tracking app is operational in 15 languages including Polish, Korean, Turkish and Hindi.
ObsEva (Switzerland)
Founders: André Chollet, Ernest Loumaye
Total Funding: €141 million
Valuation: $557 million
Founded Year: 2012
Why its hot: ObsEva is a clinical-stage biopharmaceutical company, which focuses on commercialization and development of novel therapeutics for critical conditions compromising the reproductive health of a woman. The start has a team of well-experienced and trained obstetricians. The company constantly develops new and innovative therapies to improve patients’ reproductive health.
Vitrolife (Sweden)
CEO: Thomas Axelsson
Total Funding: €18.5 million
Valuation: $140 million to $200 million
Founded Year: 1994
Why its hot: Vitrolife, a Swedish startup aims to help you fulfil your dream of having a baby. The company supports you with successful treatments and provides varied services and solutions for an assisted reproduction. It has been making a difference in the IVF field for the past 25 years and is one of the first IVF laboratories.
Anecova (Switzerland)
Founders: Martin Velasco
Total Funding: €4.3 million
Valuation: €17 million to €26 million
Why its hot: Anecova is a Swiss life science company, which aims to create a more natural and physiological approach to ART (Assisted Reproductive Technologies). The company aims to bring fertility treatments almost close to natural conception and enhance the overall quality of care provided. The first product from the company is AneVivo, which restores fertilisation and early embryo development.
WOOM Fertility (Spain)
Founders: Clelia Morales, Laurence Fontinoy
Total Funding: €2.1 million
Valuation: €4 million to €6 million
Founded Year: 2016
Why its hot: WOOM is a mobile application that is data-driven and aims to help you shorten the conception time by knowing your body and habits. Each day of the cycle is important and keeps a daily record of your sexual life and fertility to improve predictions and let you adapt to your requirements.
Finox Biotech (Switzerland)
CEO: Gavin Jelic
Total Funding: €2.1 million
Valuation: $194 million
Founded Year: 2007
Why its hot: Finox Holding is a Swiss biotechnology company engaged in the development and commercialisation of innovative and cost-effective products related to female fertility. Finox’s product, BEMFOLA is a recombinant-human Follicle Stimulating Hormone (r-hFSH). It was the first biosimilar r-hFSH launched in Europe.
Fertility Focus (UK)
CEO: Rob Milnes
Total Funding: €1.6 million
Valuation: £5 million to £8 million
Founded Year: 2006
Why its hot: Fertility Focus brings a new approach to handle infertility diagnosis and treatment. It offers many solutions including OvuSense and FertiloScope. Unlike other fertility monitors and apps, OvuSense helps diagnose fertility-related issues and monitor the treatment successfully. It analyses reproductive cycle patterns with great accuracy levels.
trackle (Germany)
Founders: Franka Futterlieb, Jörn Alraun, Katrin Reuter, Maxim Loick, Stephan Noller
Founded Year: 2015
Why its hot: trackle helps women raise body awareness so that they know when they are fertile, which is important to plan their pregnancy. Once you enter your cervical mucus status into the app, it will calculate your chances of pregnancy that day. This method combines temperature values and individual symptoms to get precise statements.
Stock Photos from videodoctor/Shutterstock
Stay tuned to Silicon Canals for more updates in the tech startup world.
Also read,
French deep tech AI scaleup METRON raises €10M funding, aims to expand globally now
